Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new Revision entry v3.5.3 has been added to the Record History, replacing the previous v3.5.2. This update reflects a change to the page's version history rather than to the study data or descriptions.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision v3.5.2 has been added to the history. Revision v3.5.0 has been removed from the history.SummaryDifference0.1%

- Check54 days agoChange DetectedThe Record History includes a new revision entry v3.5.0 and removes the previous revision v3.4.3.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded a new site revision note (v3.4.2) and removed an old operational notice about government funding; these are administrative updates and do not alter study records or user workflows. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check97 days agoChange DetectedThe page adds a government funding lapse notice with links about operating status and shows a new site revision tag (v3.4.1), while the previous revision tag (v3.4.0) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.